21/11/2005 (Agence Europe) - New rules on fees for registration of medicines for human and veterinary use at the European Medicines Agency (EMEA) have been adopted by the Council, upon a proposal from the European Commission. A number of fees will be reduced, reinforcing the principle of proportionality between the fee levels and the services provided by EMEA. The new regulation puts the fees system in line with the new pharmaceutical legislation in the EU and the new responsibilities...